HEOR News
NICE’s Early Value Assessment for Medtech: Panning for Nuggets of Innovation Gold (NICE)
Jeanette Kusel, Mark Salmon, and Sarah Byron at NICE write about how the organization’s Early Value Assessment for Medtech will rapidly evaluate the value and clinical effectiveness of digital products, devices, and diagnostics.
Read more
Lack of Innovation Set to Undermine Antibiotic Performance and Health Gains (WHO)
The organization says in its annual pipeline report that the rate of development for new antibacterial treatments is not growing fast enough to address the threat of antibiotic resistance.
Read more
Industry-Funded Studies on Cost-Effectiveness Often Favor Pricier Drugs, Study Finds (Pharmalot)
A study in the BMJ found that one-third of the cost-effectiveness studies done by pharma companies ended in more favorable results than independently done analyses, with industry-sponsored studies twice as likely to report that a medicine was more cost-effective when using the quality-adjusted life year to determine a medication’s value.
Read more
Dubai Health Authority Launches First-of-Its-Kind Value-Based Healthcare Model (Arabian Business News)
The EJADAH program will assist healthcare service providers to frame evidence-based guidelines for physicians to follow with regard to treatment protocols for all ailments, in an effort to enhance healthcare and reduce unnecessary costs.
Read more
Parliamentary Panel to Discuss Affordability of Cancer Treatment With Health Secretary (ET Healthworld.com)
India’s Parliamentary Committee on Health and Family Welfare met to discuss the rising cost of cancer care in the country and the growing proportion of the cost of nonmedical services for this care.
Read more
Saudi Arabia to Invest $3.4 Billion Into Vaccines and Vital Medicines (Arabian Business News)
The goal of the investment is to achieve pharmaceutical and health security for the kingdom, with the first phase localizing the production of vaccines, plasma, and insulin technologies.
Read more
Potential Medicare Part D Savings on Generic Drugs From the Mark Cuban Cost Plus Drug Company (Annals of Internal Medicine)
According to this analysis, if Medicare had bought generic medications through the Mark Cuban pharmacy, it could have saved up to $3.6 billion in 2020.
Read more
European Researchers Seek Greater Stake in Drug Development in Bid to Improve Access (STAT News)
Universities in Europe want more control over their intellectual property that is being used in drug research in an effort to improve access to the final product. However, these institutions are not finding this quest easy.
Read more
Lawmakers “Disheartened” by CMS Oversight of Medicare Advantage Amid Coverage Denials, Overpayments (Fierce Healthcare)
Members of the US House of Representatives want the Centers for Medicare and Medicaid Services to increase its scrutiny of Medicare Advantage plans, sparked by reports of overspending and consumer complaints of coverage denials.
Read more
Commonwealth Leaders Recommit to Ending Malaria and Neglected Tropical Diseases (WHO)
Heads of state and government from Commonwealth countries have reaffirmed their commitment to ending malaria by 2030.
Read more
